Foundations, charities, and non-profit organizations play a vital role in shaping the future of cancer care. From funding research to supporting patients and raising awareness, these groups bring trust, education, and community connection.
The miRoncol Real-time Multi-Cancer Early Risk Assessment provides an opportunity to collaborate on awareness, outreach, and education ensuring that individuals and families understand how molecular signals can complement existing screening and prevention strategies.
Co-develop materials to explain how molecular biology supports early cancer awareness.
Integrate early risk assessment into wellness, prevention, and survivorship initiatives.
Help shape the conversation on cancer prevention and the future of proactive healthcare.
Support studied projects, outreach studies, or awareness campaigns.
miRoncol can co-design programs with foundations, including donations and in-kind support, to expand impact and reach.
miRoncol’s test is not diagnostic and is not a substitute for conventional screening programs. Partnerships must emphasize responsible communication and physician-guided interpretation.
By partnering with miRoncol, foundations and non-profits can help bring meaningful early awareness to more people shaping a healthier future together.